|
|
|
Volumn 10, Issue 51, 2001, Pages 9-11
|
|
Repaglinide and diabetes. No better than glucose-lowering sulphonamides
[No Author Info available]
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ALPHA GLUCOSIDASE INHIBITOR;
CARBAMAZEPINE;
CYTOCHROME P450 3A4;
ENZYME INHIBITOR;
FLUCONAZOLE;
GLIBENCLAMIDE;
GLICLAZIDE;
GLIPIZIDE;
GLUCOSE;
GRISEOFULVIN;
INSULIN;
ITRACONAZOLE;
MACROLIDE;
METFORMIN;
PHENYTOIN;
REPAGLINIDE;
RIFABUTIN;
RIFAMPICIN;
SPIRAMYCIN;
SULFONAMIDE;
ANTIDIABETIC AGENT;
ANTIINFECTIVE AGENT;
CARBAMIC ACID DERIVATIVE;
PIPERIDINE DERIVATIVE;
ANGINA PECTORIS;
ARTICLE;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DOSE RESPONSE;
DRUG BIOAVAILABILITY;
DRUG COST;
DRUG EFFICACY;
DRUG INDICATION;
DRUG METABOLISM;
DRUG POTENTIATION;
DRUG TOLERABILITY;
ENZYME INDUCTION;
ENZYME INHIBITION;
GLUCOSE BLOOD LEVEL;
HEART INFARCTION;
HUMAN;
HYPOGLYCEMIA;
NON INSULIN DEPENDENT DIABETES MELLITUS;
CHEMICALLY INDUCED DISORDER;
COMPARATIVE STUDY;
ECONOMICS;
TREATMENT OUTCOME;
ANTI-INFECTIVE AGENTS;
CARBAMATES;
DIABETES MELLITUS, TYPE 2;
HUMANS;
HYPOGLYCEMIA;
HYPOGLYCEMIC AGENTS;
PIPERIDINES;
SULFONAMIDES;
TREATMENT OUTCOME;
|
|
EID: 0035066215
PISSN: 11677422
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
|
Times cited : (2)
|
|
References (26)
|
